Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released May 12, 2014, after the close
10-Q filed May 12, 2014, 42 days after period end · 0001144204-14-029264
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Revenue | $4.17K | $102.50K | $156.25K | — |
| Net Income | -$5.92M | -$3.59M | -$2.45M | -$3.10M |
| EPS Diluted |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.07 |
| -$0.05 |
| -$0.05 |
| -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
